Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 2
2006 2
2007 2
2008 1
2009 1
2010 3
2011 2
2015 2
2017 1
2018 1
2020 3
2021 4
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
A mixture-like model for tumor-immune system interactions.
Fotso CT, Girel S, Anjuère F, Braud VM, Hubert F, Goudon T. Fotso CT, et al. Among authors: anjuere f. J Theor Biol. 2024 Mar 21;581:111738. doi: 10.1016/j.jtbi.2024.111738. Epub 2024 Jan 24. J Theor Biol. 2024. PMID: 38278343
Autofluorescence identifies highly phagocytic tissue-resident macrophages in mouse and human skin and cutaneous squamous cell carcinoma.
Bourdely P, Petti L, Khou S, Meghraoui-Kheddar A, Elaldi R, Cazareth J, Mossadegh-Keller N, Boyer J, Sieweke MH, Poissonnet G, Sudaka A, Braud VM, Anjuère F. Bourdely P, et al. Among authors: anjuere f. Front Immunol. 2022 Oct 17;13:903069. doi: 10.3389/fimmu.2022.903069. eCollection 2022. Front Immunol. 2022. PMID: 36325333 Free PMC article.
LLT1-CD161 Interaction in Cancer: Promises and Challenges.
Braud VM, Meghraoui-Kheddar A, Elaldi R, Petti L, Germain C, Anjuère F. Braud VM, et al. Among authors: anjuere f. Front Immunol. 2022 Feb 4;13:847576. doi: 10.3389/fimmu.2022.847576. eCollection 2022. Front Immunol. 2022. PMID: 35185935 Free PMC article. Review.
Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes.
Spenlé C, Loustau T, Burckel H, Riegel G, Abou Faycal C, Li C, Yilmaz A, Petti L, Steinbach F, Ahowesso C, Jost C, Paul N, Carapito R, Noël G, Anjuère F, Salomé N, Orend G. Spenlé C, et al. Among authors: anjuere f. Front Immunol. 2021 Jul 5;12:636108. doi: 10.3389/fimmu.2021.636108. eCollection 2021. Front Immunol. 2021. PMID: 34290694 Free PMC article.
Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions.
Luci C, Bihl F, Bourdely P, Khou S, Popa A, Meghraoui-Kheddar A, Vermeulen O, Elaldi R, Poissonnet G, Sudaka A, Bozec A, Bekri S, Cazareth J, Ponzio G, Barbry P, Rezzonico R, Mari B, Braud VM, Anjuère F. Luci C, et al. Among authors: anjuere f. J Invest Dermatol. 2021 Oct;141(10):2369-2379. doi: 10.1016/j.jid.2021.03.018. Epub 2021 Apr 5. J Invest Dermatol. 2021. PMID: 33831432 Free article.
Tenascin-C Orchestrates an Immune-Suppressive Tumor Microenvironment in Oral Squamous Cell Carcinoma.
Spenlé C, Loustau T, Murdamoothoo D, Erne W, Beghelli-de la Forest Divonne S, Veber R, Petti L, Bourdely P, Mörgelin M, Brauchle EM, Cremel G, Randrianarisoa V, Camara A, Rekima S, Schaub S, Nouhen K, Imhof T, Hansen U, Paul N, Carapito R, Pythoud N, Hirschler A, Carapito C, Dumortier H, Mueller CG, Koch M, Schenke-Layland K, Kon S, Sudaka A, Anjuère F, Van Obberghen-Schilling E, Orend G. Spenlé C, et al. Among authors: anjuere f. Cancer Immunol Res. 2020 Sep;8(9):1122-1138. doi: 10.1158/2326-6066.CIR-20-0074. Epub 2020 Jul 14. Cancer Immunol Res. 2020. PMID: 32665262 Free article.
33 results